Literature DB >> 16736377

Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia.

Ketevan Stvilia1, Tengiz Tsertsvadze, Lali Sharvadze, Malvina Aladashvili, Carlos del Rio, Mark H Kuniholm, Kenrad E Nelson.   

Abstract

Injection drug use and associated hepatitis C virus (HCV) and HIV infections are on the rise in Russia and the republics of the former Soviet Union. While small targeted studies have found widespread drug use and disease among at-risk populations, there have been few attempts to comprehensively evaluate the extent of these epidemics in general post-Soviet societies. We conducted a two-stage cluster randomized survey of the entire adult population of T'bilisi, Republic of Georgia and assessed the burden of HCV, HIV, and risk behaviors for blood-borne infections in 2,000 study participants. Of the 2,000 surveyed individuals, 162 (8.1%) had injected illicit drugs during their lifetimes. Of the individuals who had injected illicit drugs, 138 (85.2%) reported sharing needles with injection partners. HCV was found in 134 (6.7%) of the total surveyed population, but in 114 (70.4%) of those who had injected illicit drugs. We found HIV in only three (0.2%) individuals, all of whom had injected illicit drugs. Injection drug use and high-risk injection practices are very common in Georgia and may be harbingers of a large burden of HCV-associated liver diseases and a potentially serious HIV epidemic in the years to come.

Entities:  

Mesh:

Year:  2006        PMID: 16736377      PMCID: PMC2527157          DOI: 10.1007/s11524-006-9032-y

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  20 in total

1.  Injection drug use, commercial sex work, and the HIV/STI epidemic in the Russian Federation.

Authors:  Catherine M Lowndes; Michel Alary; Lucy Platt
Journal:  Sex Transm Dis       Date:  2003-01       Impact factor: 2.830

Review 2.  The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe.

Authors:  Jeffrey A Kelly; Yuri A Amirkhanian
Journal:  Int J STD AIDS       Date:  2003-06       Impact factor: 1.359

3.  Second-generation HIV surveillance: better data for decision-making.

Authors:  Thomas Rehle; Stefano Lazzari; Gina Dallabetta; Emil Asamoah-Odei
Journal:  Bull World Health Organ       Date:  2004-03-16       Impact factor: 9.408

4.  Russia confronts the threat of AIDS.

Authors:  Ben Aris
Journal:  Lancet       Date:  2004 Dec 4-10       Impact factor: 79.321

Review 5.  Paying for blood donations: still a risk?

Authors:  C L van der Poel; E Seifried; W P Schaasberg
Journal:  Vox Sang       Date:  2002-11       Impact factor: 2.144

6.  Hepatitis C in Lithuania: incidence, prevalence, risk factors and viral genotypes.

Authors:  A Ambrozaitis; K S Z Agminas; G Balc Iūnaite; A Widell
Journal:  Clin Diagn Virol       Date:  1995-12

Review 7.  Global burden of disease (GBD) for hepatitis C.

Authors: 
Journal:  J Clin Pharmacol       Date:  2004-01       Impact factor: 3.126

8.  Significance of sexual route of transmission of hepatitis B and C in Russia.

Authors:  M I Mikhailov; M A Gomberg; N A Dolzhanskaya; A A Koubanova
Journal:  Int J STD AIDS       Date:  2002-12       Impact factor: 1.359

9.  Risk factors for hepatitis C virus infection among blood donors in Georgia.

Authors:  Nickolas Zaller; Kenrad E Nelson; Malvina Aladashvili; Nino Badridze; Carlos del Rio; Tengiz Tsertsvadze
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Role of a sentinel surveillance system in the context of global surveillance of infectious diseases.

Authors:  Isao Arita; Miyuki Nakane; Kazunobu Kojima; Namiko Yoshihara; Takashi Nakano; Ahmed El-Gohary
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

View more
  19 in total

1.  Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.

Authors:  Tengiz Tsertsvadze; Amiran Gamkrelidze; Nikoloz Chkhartishvili; Akaki Abutidze; Lali Sharvadze; Vakhtang Kerashvili; Maia Butsashvili; David Metreveli; Lia Gvinjilia; Shaun Shadaker; Muazzam Nasrullah; Ekaterine Adamia; Stefan Zeuzem; Nezam Afdhal; Sanjeev Arora; Karla Thornton; Beth Skaggs; Tinatin Kuchuloria; Maia Lagvilava; David Sergeenko; Francisco Averhoff
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.

Authors:  Mark H Kuniholm; Malvina Aladashvili; Carlos Del Rio; Ketavan Stvilia; Nino Gabelia; Rohit A Chitale; Tengiz Tsertsvadze; Kenrad E Nelson
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

3.  Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients.

Authors:  Mark H Kuniholm; Jennifer Mark; Malvina Aladashvili; N Shubladze; G Khechinashvili; Tengiz Tsertsvadze; Carlos del Rio; Kenrad E Nelson
Journal:  Int J Infect Dis       Date:  2007-07-23       Impact factor: 3.623

4.  INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA.

Authors:  A Abutidze; N Bolokadze; N Chkhartishvili; L Sharvadze; T Tsertsvadze
Journal:  Georgian Med News       Date:  2016-03

5.  Importance and Contribution of Community, Social, and Healthcare Risk Factors for Hepatitis C Infection in Pakistan.

Authors:  Adam Trickey; Margaret T May; Charlotte Davies; Huma Qureshi; Saeed Hamid; Hassan Mahmood; Quaid Saeed; Matthew Hickman; Nancy Glass; Francisco Averhoff; Peter Vickerman
Journal:  Am J Trop Med Hyg       Date:  2017-10-12       Impact factor: 2.345

6.  Characteristics of HIV-infected women and factors associated with HCV seropositivity in the Republic of Georgia.

Authors:  Nikoloz Chkhartishvili; Louise-Anne McNutt; Perry F Smith; Tengiz Tsertsvadze
Journal:  AIDS Res Ther       Date:  2011-07-25       Impact factor: 2.250

7.  Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.

Authors:  Kiren Mitruka; Tengiz Tsertsvadze; Maia Butsashvili; Amiran Gamkrelidze; Paata Sabelashvili; Ekaterine Adamia; Mari Chokheli; Jan Drobeniuc; Liesl Hagan; Aaron M Harris; Tea Jiqia; Ana Kasradze; Stephen Ko; Vakhtang Qerashvili; Lali Sharvadze; Irina Tskhomelidze; Valeri Kvaratskhelia; Juliette Morgan; John W Ward; Francisco Averhoff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-24       Impact factor: 17.586

8.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Authors:  Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

9.  Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.

Authors:  Evan M Bloch; Eteri Kipiani; Shaun Shadaker; Maia Alkhazashvili; Lia Gvinjilia; Tinatin Kuchuloria; Nazibrola Chitadze; Sheila M Keating; Amiran Gamkrelidze; Alexander Turdziladze; Vladimer Getia; Muazzam Nasrullah; Francisco Averhoff; Mariam Izoria; Beth Skaggs
Journal:  Transfusion       Date:  2020-05-04       Impact factor: 3.337

10.  The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.

Authors:  Tengiz Tsertsvadze; Lali Sharvadze; Nikoloz Chkhartishvili; Lela Dzigua; Marine Karchava; Lana Gatserelia; Akaki Abutidze; Kenrad E Nelson
Journal:  Virol J       Date:  2016-02-03       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.